- -

Clinical Characterization and Diagnostic Approaches for Patients Reporting Hypersensitivity Reactions to Quinolones

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Clinical Characterization and Diagnostic Approaches for Patients Reporting Hypersensitivity Reactions to Quinolones

Show full item record

Doña, I.; Pérez-Sánchez, N.; Salas, M.; Barrionuevo, E.; Ruiz-San Francisco, A.; Hernández Fernández De Rojas, D.; Martí-Garrido, J.... (2020). Clinical Characterization and Diagnostic Approaches for Patients Reporting Hypersensitivity Reactions to Quinolones. Journal of Allergy and Clinical Immunology: In Practice. 8(8):2707-2714. https://doi.org/10.1016/j.jaip.2020.04.051

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/170289

Files in this item

Item Metadata

Title: Clinical Characterization and Diagnostic Approaches for Patients Reporting Hypersensitivity Reactions to Quinolones
Author: Doña, Inmaculada Pérez-Sánchez, Natalia Salas, María Barrionuevo, Esther Ruiz-San Francisco, Arturo Hernández Fernández de Rojas, Dolores Martí-Garrido, Jaume Andreu Ros, María Inmaculada López-Salgueiro, Ramón Moreno, Esther Torres, María José
UPV Unit: Universitat Politècnica de València. Departamento de Química - Departament de Química
Issued date:
Abstract:
[EN] BACKGROUND: Quinolones are the second most frequent cause of hypersensitivity reactions (HSRs) to antibiotics. A marked increase in the number of patients with HSRs to quinolones has been detected. OBJECTIVE: To ...[+]
Subjects: Adverse drug reaction , Anaphylaxis , Basophil activation test , Ciprofloxacin , Drug provocation test , Hypersensitivity , Levofloxacin , Moxifloxacin , Quinolones , Skin tests
Copyrigths: Reserva de todos los derechos
Source:
Journal of Allergy and Clinical Immunology: In Practice. (eissn: 2213-2198 )
DOI: 10.1016/j.jaip.2020.04.051
Publisher:
Elsevier
Publisher version: https://doi.org/10.1016/j.jaip.2020.04.051
Project ID:
info:eu-repo/grantAgreement/ISCIII//CM17%2F0014/
info:eu-repo/grantAgreement/MINECO//RD16%2F0006%2F0001/ES/Asma, Reacciones Adversas y Alérgicas (ARADYAL)/
MINECO/RD16/0006/0010
MINECO/RD16/0006/0019
MINECO/RD16/0006/0030
Thanks:
The present study has been supported by the Institute of Health "Carlos III" of the Ministry of Economy and Competitiveness (grants cofounded by European Regional Development Fund: RETIC ARADYALRD16/0006/0001, RD16/0006/0010, ...[+]
Type: Artículo

References

Campi, P., & Pichler, W. J. (2003). Quinolone hypersensitivity. Current Opinion in Allergy and Clinical Immunology, 3(4), 275-281. doi:10.1097/00130832-200308000-00007

Zhanel, G. G., Ennis, K., Vercaigne, L., Walkty, A., Gin, A. S., Embil, J., … Hoban, D. J. (2002). A Critical Review of the Fluoroquinolones. Drugs, 62(1), 13-59. doi:10.2165/00003495-200262010-00002

Bertino, J., & Fish, D. (2000). The safety profile of the fluoroquinolones. Clinical Therapeutics, 22(7), 798-817. doi:10.1016/s0149-2918(00)80053-3 [+]
Campi, P., & Pichler, W. J. (2003). Quinolone hypersensitivity. Current Opinion in Allergy and Clinical Immunology, 3(4), 275-281. doi:10.1097/00130832-200308000-00007

Zhanel, G. G., Ennis, K., Vercaigne, L., Walkty, A., Gin, A. S., Embil, J., … Hoban, D. J. (2002). A Critical Review of the Fluoroquinolones. Drugs, 62(1), 13-59. doi:10.2165/00003495-200262010-00002

Bertino, J., & Fish, D. (2000). The safety profile of the fluoroquinolones. Clinical Therapeutics, 22(7), 798-817. doi:10.1016/s0149-2918(00)80053-3

Ho, D. Y., Song, J. C., & Wang, C. C. (2003). Anaphylactoid Reaction to Ciprofloxacin. Annals of Pharmacotherapy, 37(7-8), 1018-1023. doi:10.1345/aph.1c498

Demoly, P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., … Thong, B. Y.-H. (2014). International Consensus on drug allergy. Allergy, 69(4), 420-437. doi:10.1111/all.12350

Schmid, D. A., Depta, J. P. H., & Pichler, W. J. (2006). T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clinical <html_ent glyph=«@amp;» ascii=«&amp;»/> Experimental Allergy, 36(1), 59-69. doi:10.1111/j.1365-2222.2006.02402.x

Jones, S. C., Budnitz, D. S., Sorbello, A., & Mehta, H. (2013). US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. Pharmacoepidemiology and Drug Safety, 22(10), 1099-1106. doi:10.1002/pds.3499

Sachs, B., Fischer-Barth, W., & Merk, H. F. (2015). Reporting rates for severe hypersensitivity reactions associated with prescription-only drugs in outpatient treatment in Germany. Pharmacoepidemiology and Drug Safety, 24(10), 1076-1084. doi:10.1002/pds.3857

McNeil, B. D., Pundir, P., Meeker, S., Han, L., Undem, B. J., Kulka, M., & Dong, X. (2014). Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature, 519(7542), 237-241. doi:10.1038/nature14022

Van Gasse, A. L., Sabato, V., Uyttebroek, A. P., Elst, J., Faber, M. A., Hagendorens, M. M., … Ebo, D. G. (2017). Immediate moxifloxacin hypersensitivity: Is there more than currently meets the eye? Allergy, 72(12), 2039-2043. doi:10.1111/all.13236

Porebski, G., Kwiecien, K., Pawica, M., & Kwitniewski, M. (2018). Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions. Frontiers in Immunology, 9. doi:10.3389/fimmu.2018.03027

González-Gregori, R., Dolores Hernández Fernandez De Rojas, M., López-Salgueiro, R., Díaz-Palacios, M., & García, A. N. (2012). Allergy alerts in electronic health records for hospitalized patients. Annals of Allergy, Asthma & Immunology, 109(2), 137-140. doi:10.1016/j.anai.2012.06.006

Renaudin, J.-M., Beaudouin, E., Ponvert, C., Demoly, P., & Moneret-Vautrin, D.-A. (2013). Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy, 68(7), 929-937. doi:10.1111/all.12168

Blanca-López, N., Ariza, A., Doña, I., Mayorga, C., Montañez, M. I., Garcia-Campos, J., … Torres, M. J. (2013). Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clinical & Experimental Allergy, 43(5), 560-567. doi:10.1111/cea.12099

Johannes, C. B., Ziyadeh, N., Seeger, J. D., Tucker, E., Reiter, C., & Faich, G. (2007). Incidence of Allergic Reactions Associated with Antibacterial Use in a Large, Managed Care Organisation. Drug Safety, 30(8), 705-713. doi:10.2165/00002018-200730080-00007

Kulthanan, K., Chularojanamontri, L., Manapajon, A., Dhana, N., & Jongjarearnprasert, K. (2011). Cutaneous Adverse Reactions to Fluoroquinolones. Dermatitis, 22(3), 155-160. doi:10.2310/6620.2011.10115

Neuman, M. G., Cohen, L. B., & Nanau, R. M. (2015). Quinolones-induced hypersensitivity reactions. Clinical Biochemistry, 48(10-11), 716-739. doi:10.1016/j.clinbiochem.2015.04.006

Phillips, C. J., Gilchrist, M., Cooke, F. J., Franklin, B. D., Enoch, D. A., Murphy, M. E., … Holmes, A. H. (2019). Adherence to antibiotic guidelines and reported penicillin allergy: pooled cohort data on prescribing and allergy documentation from two English National Health Service (NHS) trusts. BMJ Open, 9(2), e026624. doi:10.1136/bmjopen-2018-026624

Dávila, I., Diez, M. L., Quirce, S., Fraj, J., Hoz, B., & Lazaro, M. (1993). Cross-reactivity between quinolones. Allergy, 48(5), 388-390. doi:10.1111/j.1398-9995.1993.tb02413.x

Scherer, K., & Bircher, A. J. (2005). Hypersensitivity reactions to fluoroquinolones. Current Allergy and Asthma Reports, 5(1), 15-21. doi:10.1007/s11882-005-0049-1

Brockow, K., Garvey, L. H., Aberer, W., Atanaskovic-Markovic, M., Barbaud, A., … Bilo, M. B. (2013). Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy, 68(6), 702-712. doi:10.1111/all.12142

Manfredi, M., Severino, M., Testi, S., Macchia, D., Ermini, G., Pichler, W. J., & Campi, P. (2004). Detection of specific IgE to quinolones. Journal of Allergy and Clinical Immunology, 113(1), 155-160. doi:10.1016/j.jaci.2003.09.035

Aranda, A., Mayorga, C., Ariza, A., Doña, I., Rosado, A., Blanca-Lopez, N., … Torres, M. J. (2010). In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy, 66(2), 247-254. doi:10.1111/j.1398-9995.2010.02460.x

Ben Said, B., Berard, F., Bienvenu, J., Nicolas, J.-F., & Rozieres, A. (2010). Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones. Allergy, 65(4), 535-536. doi:10.1111/j.1398-9995.2009.02213.x

Mayorga, C., Celik, G., Rouzaire, P., Whitaker, P., Bonadonna, P., … Rodrigues-Cernadas, J. (2016). In vitrotests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy, 71(8), 1103-1134. doi:10.1111/all.12886

Seitz, C. S., Bröcker, E. B., & Trautmann, A. (2009). Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clinical & Experimental Allergy, 39(11), 1738-1745. doi:10.1111/j.1365-2222.2009.03338.x

Brockow, K., Ardern‐Jones, M. R., Mockenhaupt, M., Aberer, W., Barbaud, A., Caubet, J., … Mortz, C. G. (2018). EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy, 74(1), 14-27. doi:10.1111/all.13562

Valdivieso, R., Pola, J., Losada, E., Subiza, J., Armentia, A., & Zapata, C. (1988). Severe anaphylactoid reaction to nalidixic acid. Allergy, 43(1), 71-73. doi:10.1111/j.1398-9995.1988.tb02046.x

Aberer, W., Bircher, A., Romano, A., Blanca, M., Campi, P., … Fernandez, J. (2003). Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy, 58(9), 854-863. doi:10.1034/j.1398-9995.2003.00279.x

SALVO, F., POLIMENI, G., CUTRONEO, P., LEONE, R., CONFORTIC, A., MORETTI, U., … CAPUTI, A. (2008). Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF). Pharmacological Research, 58(3-4), 202-207. doi:10.1016/j.phrs.2008.07.003

Blanca, M., Romano, A., Torres, M. J., Férnandez, J., Mayorga, C., Rodriguez, J., … Atanasković-Marković, M. (2009). Update on the evaluation of hypersensitivity reactions to betalactams. Allergy, 64(2), 183-193. doi:10.1111/j.1398-9995.2008.01924.x

Bircher, A. J., & Scherer Hofmeier, K. (2012). Drug hypersensitivity reactions: Inconsistency in the use of the classification of immediate and nonimmediate reactions. Journal of Allergy and Clinical Immunology, 129(1), 263-264. doi:10.1016/j.jaci.2011.08.042

Terrados, S., Blanca, M., Garcia, J., Vega, J., Torres, M. J., Carmona, M. J., … Fernandez, J. (1995). Nonimmediate reactions to betalactams: prevalence and role of the different penicillins. Allergy, 50(7), 563-567. doi:10.1111/j.1398-9995.1995.tb01200.x

Gómez, E., Blanca-Lopez, N., Salas, M., Canto, G., Campo, P., Torres, M. J., … Blanca, M. (2013). Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms. Annals of Allergy, Asthma & Immunology, 110(4), 267-273. doi:10.1016/j.anai.2013.01.003

Blanca-López, N., Pérez-Sánchez, N., Agúndez, J. A., García-Martin, E., Torres, M. J., Cornejo-García, J. A., … Doña, I. (2016). Allergic Reactions to Metamizole: Immediate and Delayed Responses. International Archives of Allergy and Immunology, 169(4), 223-230. doi:10.1159/000444798

Alonso, M. D., Martín, J. A., Quirce, S., Dávila, I., Lezaun, A., & Cano, M. S. (1993). Fixed eruption caused by ciprofloxacin with cross-sensitivity to norfloxacin. Allergy, 48(4), 296-297. doi:10.1111/j.1398-9995.1993.tb00733.x

Davila, G., Ruiz-Hornillos, J., Rojas, P., De Castro, F., & Zubeldia, J. M. (2009). TOXIC EPIDERMAL NECROLYSIS INDUCED BY LEVOFLOXACIN. Annals of Allergy, Asthma & Immunology, 102(5), 441-442. doi:10.1016/s1081-1206(10)60521-2

Ayllón, M. L., Martinez, M. G., Mosquera, M. R., Laguna Martinez, J. J., Martiartu, M. O., & Fernández de Miguel, C. (1995). Fixed eruption caused by ciprofloxacin without cross-sensitivity to norfloxacin. Allergy, 50(7), 598-599. doi:10.1111/j.1398-9995.1995.tb01206.x

Empedrad, R. (2003). Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. Journal of Allergy and Clinical Immunology, 112(3), 629-630. doi:10.1016/s0091-6749(03)01783-4

Brož, P., Harr, T., Hecking, C., Grize, L., Scherer, K., Jaeger, K. A., & Bircher, A. J. (2012). Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. Allergy, 67(5), 647-652. doi:10.1111/j.1398-9995.2012.02807.x

Uyttebroek, A. P., Sabato, V., Bridts, C. H., De Clerck, L. S., & Ebo, D. G. (2015). Moxifloxacin hypersensitivity: Uselessness of skin testing. The Journal of Allergy and Clinical Immunology: In Practice, 3(3), 443-445. doi:10.1016/j.jaip.2014.12.012

Fernandez-Rivas, M. (1997). Fixed drug eruption (FDE) caused by norfloxacin. Allergy, 52(4), 477-478. doi:10.1111/j.1398-9995.1997.tb01035.x

Chang, B., Knowles, S. R., & Weber, E. (2010). Immediate Hypersensitivity to Moxifloxacin with Tolerance to Ciprofloxacin: Report of Three Cases and Review of the Literature. Annals of Pharmacotherapy, 44(4), 740-745. doi:10.1345/aph.1m579

Sánchez-Morillas, L., Rojas Pérez-Ezquerra, P., Reaño-Martos, M., Laguna-Martínez, J. J., & Gómez-Tembleque, P. (2010). Systemic anaphylaxis caused by moxifloxacin. Allergologia et Immunopathologia, 38(4), 226-227. doi:10.1016/j.aller.2009.09.008

[-]

recommendations

 

This item appears in the following Collection(s)

Show full item record